HPV vaccination and sexual health in France: Empowering girls to decide.
Adolescent
Decision Making
Female
France
/ epidemiology
Health Knowledge, Attitudes, Practice
Humans
Male
Papillomavirus Infections
/ complications
Papillomavirus Vaccines
/ administration & dosage
Patient Acceptance of Health Care
Public Health Surveillance
Qualitative Research
Risk
Sexual Health
Uterine Cervical Neoplasms
/ etiology
Adolescent
Attitudes
HPV
Human papillomavirus
Qualitative research
Vaccines
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
22 03 2019
22 03 2019
Historique:
received:
09
10
2018
revised:
30
01
2019
accepted:
05
02
2019
pubmed:
28
2
2019
medline:
13
8
2020
entrez:
28
2
2019
Statut:
ppublish
Résumé
Vaccination coverage against HPV in France is among the lowest in the industrialized world, although the public authorities have recently become aware of this issue. Few studies have looked at teenaged girls' representations of this vaccination, even though they are the most concerned by it. This qualitative study explored the experiences and representations of HPV vaccination by adolescent girls seeing doctors at least occasionally. We used a written essay question to explore this issue among 101 adolescent girls at six urban medical centers and a semi-structured interview to discuss it in further depth with five of them. The analysis was lexicometric (ALCESTE®) and phenomenological (Interpretative Phenomenological Analysis). These results are organized around four superordinate themes: the teenage girls' factual knowledge about this vaccine, their motives for and obstacles to vaccination, their involvement in this decision, and finally the need for information about and solutions to this issue. Teenage girls know little about this vaccine and are more sensitive to the emotional discourse that surrounds it than to rational knowledge about it. The requirement for parental authorization for this vaccine reinforces the girls' lack of investment. Vaccination programs should integrate the HPV vaccine more thoroughly into general prevention concerning sexual health and should send a strong signal by offering minors anonymous vaccination free of charge, as is already the case in France for requests for contraception, the morning-after pill, elective abortion, and screening and treatment of sexually transmitted infections.
Identifiants
pubmed: 30808568
pii: S0264-410X(19)30215-4
doi: 10.1016/j.vaccine.2019.02.020
pii:
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1792-1798Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.